San Francisco-based Viz.ai said in a news release that the new modules allow for faster clinical decision making and improved care coordination for patients with the two life-threatening conditions. The company is debuting the modules at the 48th annual VEITHsymposium November 16 – 20 in Orlando, Florida.
The modules use deep learning to identify suspected aortic dissection and pulmonary embolism disease in under two minutes. Viz.ai designed them to ensure that the correct clinical decisions are made at the right time regardless of where a patient resides in the healthcare system.
Users can access all aortic and pulmonary imaging from the cloud, while the modules use their advanced deep learning capabilities to communicate time-sensitive information, including advanced imaging studies and real-time clinical information.
Viz.ai said it stands as the only software company to offer an AI-powered care coordination solution for stroke, aortic disease and pulmonary embolism. The company’s stroke platform received CE mark earlier this year.
“The launch of these two new modules brings the power of the Viz platform to a vast new faction of medical professionals and patients battling life-threatening conditions,” Viz.ai CEO & Co-Founder Dr. Chris Mansi said in the release. “This is a significant milestone in our mission to fundamentally improve how healthcare is delivered in the world.”